A) Inhibition of DNA replication B) Inhibition of protein synthesis C) Inhibition of cell wall synthesis D) Disruption of cell membrane integrity
A) Ribosomes B) Peptidoglycan layer of bacterial cell walls C) Cell membrane lipids D) Nucleoid region
A) Facilitate the final transpeptidation step in peptidoglycan synthesis B) Generate energy for the cell C) Synthesize nucleic acids D) Transport nutrients across the cell membrane
A) Penicillin binding proteins (PBPs) B) Lipoproteins C) DNA polymerases D) Ribosomal proteins
A) Allows them to penetrate the bacterial cell membrane B) Facilitates their binding to the active site of PBPs C) Enables them to inhibit ribosomal function D) Helps them to bind to DNA
A) Arg75 B) Ser62 C) Glu100 D) Lys50
A) Enhancement of peptidoglycan synthesis B) Activation of bacterial DNA replication C) Prevention of the final crosslinking of the peptidoglycan layer D) Stimulation of bacterial cell division
A) Fungi B) Bacteria, including cyanobacteria, cyanelles, and chloroplasts of bryophytes C) Viruses D) Vascular plants
A) Disruption of photosynthesis B) Induction of cell death C) No effect D) Inhibition of division
A) Theory of spontaneous generation B) Germ theory of disease C) Cell theory D) Endosymbiotic theory
A) Build-up of peptidoglycan precursors B) High temperature C) Absence of nutrients D) Presence of β-lactam antibiotics
A) By increasing bacterial cell wall synthesis B) By promoting bacterial cell division C) By inhibiting bacterial DNA replication D) By causing the digestion of existing peptidoglycan without new production
A) Methicillin-resistant enzyme B) Aminoglycoside acetyltransferase C) β-lactamase D) Penicillinase
A) Protease inhibitors B) Reverse transcriptase inhibitors C) Integrase inhibitors D) β-lactamase inhibitors such as clavulanic acid
A) Hypertension B) Diarrhea C) Hyperglycemia D) Bradycardia
A) Approximately 5% B) Approximately 2% or less C) Approximately 10% D) Approximately 15%
A) Approximately 15% B) Less than 1% C) Approximately 5% D) Approximately 10%
A) Tzanck reaction B) Anaphylactic reaction C) Jarisch–Herxheimer reaction D) Serum sickness
A) The solubility of the β-lactam antibiotic B) Cohen's parameter (c) C) Woodward's parameter (h) D) The molecular weight of the β-lactam antibiotic
A) The molecular weight of the β-lactam antibiotic B) Woodward's parameter (h) C) The solubility of the β-lactam antibiotic D) Cohen's parameter (c)
A) Lower h values B) Zero h values C) Constant h values D) Higher h values
A) Zero c values B) Higher c values C) Constant c values D) Lower c values
A) Thymine dimers B) Double-strand breaks C) 8-oxo-2'-deoxyguanosine lesions D) Single-strand breaks
A) A β-lactam ring B) A hydroxyl group C) A carboxylate group D) An amide bond
A) Piperacillin/tazobactam B) Ceftriaxone/nitrocefin C) Amoxicillin/clavulanic acid D) Ceftriaxone/meropenem
A) An auxiliary ring with a carboxylate group B) A hydroxyl group C) A β-lactamase inhibitor D) An amide bond
A) Amoxicillin B) Meropenem C) Clavulanic acid D) Ceftriaxone
A) It influences the antibiotic's solubility B) It is essential for the antibiotic's antimicrobial activity C) It determines the antibiotic's color D) It affects the antibiotic's taste
A) Penems B) Penams C) Carbapenams D) Oxapenams
A) β-lactam synthetase B) Nonribosomal peptide synthetase C) Isopenicillin N synthase (IPNS) D) ACV synthetase (ACVS)
A) Isopenicillin N B) Monobactam C) Cephem D) Carbapenem
A) ACV synthetase (ACVS) B) β-lactam synthetase C) Nonribosomal peptide synthetase D) Isopenicillin N synthase (IPNS)
A) Position 4 B) Position 1 C) Position 5 D) Position 3
A) Cephems B) Monobactams C) Penems D) Carbapenems
A) Carbapenems B) Cephems C) Monobactams D) Penams
A) Carbacephems B) Oxacephems C) Monobactams D) Cephems
A) Cephems B) Oxacephems C) Carbacephems D) Monobactams
A) Cephems B) Penems C) Carbapenems D) Monobactams
A) Cephems B) Carbacephems C) Oxacephems D) Monobactams
A) Oxapenams B) Penams C) Penems D) Carbapenams |